Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma.
Br J Haematol. 2020 Jun;189(6):1136-1140. doi: 10.1111/bjh.16454. Epub 2020 Feb 3.
Br J Haematol. 2020.
PMID: 32012228
Free PMC article.
Clinical Trial.
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.
Chakraborty R, Rybicki L, Nakashima MO, Dean RM, Faiman BM, Samaras CJ, Rosko N, Dysert H, Valent J, Anwer F.
Chakraborty R, et al. Among authors: dysert h.
Br J Haematol. 2020 Jun;189(6):1074-1082. doi: 10.1111/bjh.16488. Epub 2020 Feb 28.
Br J Haematol. 2020.
PMID: 32108328
Free PMC article.
Clinical Trial.
Item in Clipboard
Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma.
Hu Y, Liu H, Fang C, Li C, Xhyliu F, Dysert H, Bodo J, Habermehl G, Russell BE, Li W, Chappell M, Jiang X, Ondrejka SL, Hsi ED, Maciejewski JP, Yi Q, Anderson KC, Munshi NC, Ao G, Valent JN, Lin J, Zhao J.
Hu Y, et al. Among authors: dysert h.
Cancer Res. 2020 May 15;80(10):2031-2044. doi: 10.1158/0008-5472.CAN-19-1077. Epub 2020 Mar 19.
Cancer Res. 2020.
PMID: 32193289
Free PMC article.
Item in Clipboard
Cite
Cite